{"text": "Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> single-chain intrabodies and NF-kappa B antagonists .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Human immunodeficiency virus type 1 ( HIV-1 ) <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> , an early regulatory protein that is critical for viral gene expression and replication , transactivates the HIV-1 long terminal repeat ( LTR ) via its binding to the transactivation response element ( TAR ) and , along with other cellular factors , increases viral transcription initiation and elongation .", "event": "<extra_id_0> <extra_id_0> Binding binding <extra_id_0> Theme Tat <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> Tat <extra_id_2> Protein <extra_id_1> also superactivates the HIV-1 promoter through a TAR - independent mechanism , including <extra_id_0> tumor necrosis factor alpha <extra_id_2> Protein <extra_id_1> - induced and protein kinase C ( PKC ) - dependent activation of NF-kappa B , and inhibitors of <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> and NF-kappa B cooperatively down-regulate this <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> - mediated LTR superactivation .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In this study , a combined pharmacologic and genetic strategy using two PKC ( NF-kappa B ) inhibitors , pentoxifylline ( PTX ) and Go-6976 , and a stably expressed anti - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> single-chain intracellular antibody ( sFv intrabody ) was employed to obtain cooperative inhibition of both HIV-1 LTR - driven gene expression and HIV-1 replication .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Treatment of cells with PTX and Go-6976 resulted in cooperative inhibition of both HIV-1 LTR - driven gene expression and HIV-1 replication .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In addition , the combined use of anti - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> sFv intrabodies and the two NF-kappa B inhibitors retained the virus in the latent state for as long as 45 days .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The combined treatment resulted in more durable inhibition of HIV-1 replication than was seen with the NF-kappa B inhibitors alone or the anti - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> sFv intrabodies alone .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Together , these results suggest that in future clinical gene therapy trials , a combined pharmacologic and genetic strategy like the one reported here may improve the survival of transduced cells and prolong clinical benefit .", "event": "<extra_id_0> <extra_id_1>"}
